Allianz SE

SEC CIK: 0001127508
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

CLDX holding history

Celldex Therapeutics, Inc. in every 13F filed by Allianz SE, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CLDX overview All 13F holders of CLDX Full Q2 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2024

Holdings of CLDX by Allianz SE, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−1,400−100.0%	Sold out	Holders
Q2 2024	1,400	$51.8K	<0.1%	00.0%	Unchanged	Holders
Q1 2024	1,400	$58.8K	<0.1%	–	No prior filing	Holders